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ABSTRACT
Bayesian Methods in Bioinformatics. (December 2005)
Veerabhadran Baladandayuthapani, B.Sc., Indian Institute of Technology,
Kharagpur India;
M.A., University of Rochester
Co-Chairs of Advisory Committee: Dr. Raymond J. Carroll
Dr. Bani K. Mallick
This work is directed towards developing flexible Bayesian statistical methods
in the semi- and nonparamteric regression modeling framework with special focus on
analyzing data from biological and genetic experiments. This dissertation attempts to
solve two such problems in this area. In the first part, we study penalized regression
splines (P-splines), which are low–order basis splines with a penalty to avoid under-
smoothing. Such P–splines are typically not spatially adaptive, and hence can have
trouble when functions are varying rapidly. We model the penalty parameter inherent
in the P–spline method as a heteroscedastic regression function. We develop a full
Bayesian hierarchical structure to do this and use Markov Chain Monte Carlo tech-
niques for drawing random samples from the posterior for inference. We show that
the approach achieves very competitive performance as compared to other methods.
The second part focuses on modeling DNA microarray data. Microarray technology
enables us to monitor the expression levels of thousands of genes simultaneously and
hence to obtain a better picture of the interactions between the genes. In order to
understand the biological structure underlying these gene interactions, we present a
hierarchical nonparametric Bayesian model based on Multivariate Adaptive Regres-
iv
sion Splines (MARS) to capture the functional relationship between genes and also
between genes and disease status. The novelty of the approach lies in the attempt to
capture the complex nonlinear dependencies between the genes which could otherwise
be missed by linear approaches. The Bayesian model is flexible enough to identify
significant genes of interest as well as model the functional relationships between the
genes. The effectiveness of the proposed methodology is illustrated on leukemia and
breast cancer datasets.
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1CHAPTER I
INTRODUCTION
This dissertation introduces Bayesian nonparametric regression modeling tools and
utilizes modern Markov Chain Monte Carlo (MCMC) techniques to explore the pos-
terior distributions of interest induced by the models. Bayesian methodology has
generated immense interest due to two basic reasons. First, Bayesian methods take
an axiomatic view of uncertainity allowing the user to make coherent inference and
second, Bayesian modeling is particularly well suited to incorporating prior infor-
mation, which is often available. Special focus is on developing Bayesian statistical
machinery for modeling data from functional genomics.
In Chapter II, we study penalized regression splines (P-splines), which are low–
order basis splines with a penalty to avoid undersmoothing. Such P–splines are typ-
ically not spatially adaptive, and hence can have trouble when functions are varying
rapidly. Our approach is to model the penalty parameter inherent in the P–spline
method as a heteroscedastic regression function. We develop a full Bayesian hi-
erarchical structure to do this and use Markov Chain Monte Carlo techniques for
drawing random samples from the posterior for inference. The advantage of using
a Bayesian approach to P–splines is that it allows for simultaneous estimation of
the smooth functions and the underlying penalty curve in addition to providing un-
certainty intervals of the estimated curve. The Bayesian credible intervals obtained
for the estimated curve are shown to have pointwise coverage probabilities close to
The format and style follow that of Journal of the American Statistical Association.
2nominal. The method is extended to additive models with simultaneous spline based
penalty functions for the unknown functions. In simulations, the approach achieves
very competitive performance with the current best frequentist P–spline method in
terms of frequentist mean squared error and coverage probabilities of the credible
intervals, and performs better than some of the other Bayesian methods.
Chapter III deals with DNA microarray data. DNA microarray technology en-
ables us to monitor the expression levels of thousands of genes simultaneously, and
hence to obtain a better picture of the interactions between the genes. In order to
understand the biological structure underlying these gene interactions, we present
here a statistical approach to model the functional relationship between genes and
also between genes and disease status. We suggest a hierarchical Bayesian model
based on Multivariate Adaptive Regression Splines (MARS) to model these complex
nonlinear interaction functions. The novelty of the approach lies in the fact that
we attempt to capture the complex nonlinear dependencies between the genes which
otherwise would have been missed by linear approaches. Owing to the large number
of genes (variables) and the complexity of the data, we use MCMC based stochastic
search algorithms to choose among models. The Bayesian model is flexible enough
to identify significant genes as well as model the functional relationships between
them. The effectiveness of the proposed methodology is illustrated using two publicly
available microarray data sets: Leukemia and hereditary breast cancer.
Chapter IV provides a summary of the results in this dissertation and some open
questions are posed for future research.
3CHAPTER II
SPATIALLY ADAPTIVE BAYESIAN PENALIZED REGRESSION SPLINES∗
2.1 Introduction
Regression splines are approximations to functions typically using a low–order num-
ber of basis functions. Such splines, like all splines, are subject to a lack of smoothness
and various strategies have been proposed to attain this smoothness. A particularly
appealing class are the regression P–splines (Eilers and Marx 1996), which achieve
smoothness by penalizing the sum of squares or likelihood by a single penalty pa-
rameter. The penalty parameter and the fit using P–splines are easy to compute
using mixed model technology (see Robinson 1991; Coull, Ruppert and Wand 2001;
Rice and Wu 2001, among others), and are not sensitive to knot parameter selection
(Ruppert 2002).
Despite these advantages, P–splines with a single penalty parameter are not
suitable for spatially adaptive functions that can oscillate rapidly in some regions and
are rather smooth in other regions (Wand 2000). Rather than using a global penalty
parameter, Ruppert and Carroll (2000) proposed a local penalty method wherein the
penalty is allowed to vary spatially so as to adapt to the spatial heterogeneity in
the regression function. The web site http://orie.cornell.edu/∼davidr contains the
MATLAB code for computing this spatially adaptive estimator.
The purpose of this chapter is to construct a Bayesian version of the local
penalty method. We do this by modeling the penalty as another regression P–
spline, in effect a variance function, in a hierarchical structure. The method is rel-
∗Reprinted with permission from the Journal of Computational and Graphical Statis-
tics. Copyright 2005 by the American Statistical Association. All rights reserved.
4atively simple to compute and implement, and the MATLAB code for it is given
at http://stat.tamu.edu/∼veera. The advantage of using a Bayesian approach to P–
splines is that it allows for simultaneous estimation of the function and the underlying
penalty curve in addition to providing uncertainty intervals for the estimated curve.
We show that our method achieves competitive performance with that of Ruppert
and Carroll in terms of frequentist mean squared error and coverage probabilities of
credible intervals. The Bayesian credible intervals obtained for the estimated curve
are shown to have pointwise frequentist coverage probabilities close to nominal. In
simulations our method outperforms, sometimes substantially, many other Bayesian
methods existing in literature.
The chapter is structured as follows: Section 2.2 introduces the Bayesian model
used, along with the prior and distributional assumptions on the random variables
and parameters. Section 2.3 is devoted to the MCMC setup for the calculations.
Section 2.4 discusses the simulation study undertaken and the results of our findings.
We extend the univariate ideas to additive models in Section 2.5. Technical details
are collected into Appendix A
2.2 Model Formulation
Given data (Xi, Yi), where Xi is univariate, our nonparametric model is defined by
Yi = m(Xi) + ²i,
where m(•) is an unknown function, the ²i’s are independent conditional on Xi and
normally distributed with mean zero and variance σ2Y .
To estimatem(•) we use regression P–splines. As the basis functions, here we use
piecewise polynomial functions whose highest order derivative takes jumps at fixed
“knots”. Other basis functions such as B-splines (de Boor 1978) could also be used.
5With this basis, the functional form of the regression spline of degree p ≥ 1 is given
by
m(X) = αY 0 + αY 1X + . . .+ αY pX
p +
MY∑
j=1
βY j(X − κY j)p+,
where (αY 0, . . . , αY p, βY 1, . . . , βYMY ) is a vector of regression coefficients and (a)
p
+ =
apI(a ≥ 0), and κY 1 < . . . < κYMY are fixed knots.
To model the unknown smooth function m(•), we illustrate the theory using
regression splines of degree 1, so that
m(X) = αY 0 + αY 1X +
MY∑
j=1
βY j(X − κY j)+, (2.1)
Of course, changes to polynomials of higher degree are trivial. We take MY , the
number of knots, to be large but much less than n, the number of data points. Unlike
knot-selection techniques we retain all candidate knots. In this particular method,
we take the knots to be the equally spaced sample quantiles of X, although one could
just as easily take the knots to be equally spaced.
The number of knots here is specified by the user. Although the choice is not
crucial (Ruppert 2002) a minimum number knots are needed to capture the spatial
variability in the data. The choice of knots is discussed in detail later in the chapter
(Section 2.4.2).
We can interpret (2.1) as a Bayesian linear model. Rewrite (2.1) as
Y = ZYΩY + ²Y , (2.2)
where Yn×1 = (Y1, . . . , Yn)T , ΩY = (αY 0, αY 1, βY 1, . . . , βYMY )
T is a (MY + 2)× 1
vector of regression coefficients, ²Y = (²1, . . . , ²n)
T is n×1 error vector and the design
6matrix ZY is defined as
ZY =

1 X1 (X1 − κY 1)+ . . . (X1 − κYMY )+
1 X2 (X2 − κY 1)+ . . . (X2 − κYMY )+
...
...
...
. . .
...
1 Xn (Xn − κY 1)+ . . . (Xn − κYMY )+

.
Suppose that ²1, . . . , ²n are independent and identically distributed Normal(0, σ
2
Y ).
The parameters in (αY 0, αY 1) can be considered as fixed effects in the model. We put
a normal prior on (αY 0, αY 1) with 0 mean and large variance (say 100). This ef-
fectively acts as a non-informative uniform prior on the fixed effects. The random
variables in {βY j}MYj=1, are assumed a priori independent and normally distributed,
i.e., βY j ∼ Normal{0, σ2j (κY j)}, where j = 1, . . . ,MY . Note here that σ2j (κY j) is the
smoothing parameter (shrinkage or ridge parameter).
In the usual regression P–spline formulation with a global smoothing parameter,
the σ2j (κY j) are all constant as a function of j, so that the smoothing is not spatially
adaptive. We next describe how we extend the model to allow for spatially adaptive
smoothing.
To develop a spatially adaptive technique we need to model σ2j (κY j). This is
crucial to capturing the spatial heterogeneity of the data because different smoothing
parameters lend different amounts of smoothing in different regions. Allowing the
smoothing parameter to be spatially adaptive also helps improve the mean squared
error (MSE) of the fits, as well as the accuracy of inference (Ruppert and Carroll
2000; Wand 2000). In this spirit, we develop a hierarchical model for σ2j (κY j), where
σ2(•) is a function evaluated at the knots (κY j). The functional form of σ2(•) is taken
to be another linear regression spline, e.g., for a linear spline
−log{σ2(X)} = αs0 + αs1X +
Ms∑
k=1
βsk(X − κsk)+, (2.3)
7where again κ1 < . . . < κMs are fixed knots. The number of sub-knots Ms is again
user specified and is typically far less than MY , the number of knots in the original
spline. The knots {κk}Msk=1 are again taken to be equally spaced quantiles of X. We
now write (2.3) as a Bayesian linear model:
ρ = ZsΩs (2.4)
where ρ = [− log{σ2(κ1)}, . . . ,− log{σ2(κMY )}]T , Ωs = (αs0 , αs1 , βs1 , . . . , βsMs )T is an
(Ms+2) × 1 vector and Zs is the design matrix, identical to that for (2.2) except the
change in the knots.
The random variables in the above equation are again assumed a priori indepen-
dent and normally distributed, i.e., βsk ∼ Normal(0, ξ2), where k = 1, . . . ,Ms and
the parameters (αs0 , αs1) are again independent and normally distributed with zero
mean and large variance.
As described in Section 2.3, although the motivation as a variance function to
achieve spatially adaptive smoothing is clear, we will actually use a slight modification
of (2.3)–(2.4) in order to avoid Ωs having to be sampled by a complex Metropolis–
Hastings step.
2.3 Implementation via Markov Chain Monte Carlo Simulation
In this section we set up the framework to carry out the Markov Chain Monte
Carlo (MCMC) calculations. The prior distributions of the variance (σ2Y ) of the error
vector ²Y , and ξ
2, the variance of the βsk ’s, are taken to be a conjugate inverse gamma
distribution with parameters (aY , bY ) and (as, bs) respectively, i.e., σ
2
Y ∼ IG(aY , bY )
and ξ2 ∼ IG(as, bs), where IG(•) is the inverse gamma distribution.
The parameters and random variables to be estimated in the model are ΩY ,Ωs, ξ
2
and σ2Y . With the above model and prior set-up all the conditional distributions turn
8out to be of known standard forms except that of Ωs, which is a complex multivariate
density. Hence we need a multivariate Metropolis-Hastings (MH) step to generate
the samples. Since this involves searching over a (Ms + 2)-dimensional space for
convergence, we noticed during the simulations that the movement of the MH step
was very slow.
Hence we resort to the following device to reduce the dimension, thereby making
the moves faster. We add an error term (²u) to the functional form of σ
2(X) in
(2.3)–(2.4), leading to the model
ρ = ZsΩs + ²u, (2.5)
where ²u = Normal(0, σ
2
uI). We fix the value of σ
2
u for our simulations to = 0.01
because this variance is unidentified in the model. This device reduces the computa-
tional costs by reducing the MH step to one dimension to generate each of σ2j (κY j)’s,
which are now conditionally dependent only on Ωs and conditionally independent of
the rest of the parameters. This in effect makes the movement of the MCMC sam-
ples across the model space extremely fast and also improves the acceptance rate of
MH moves. In our simulations we found that the choice of the value of σ2u does not
have great influence on the performance of the MCMC. The complete conditional
posteriors are derived in the Appendix A.
2.4 Simulations
In this section we present simulation studies primarily to evaluate the frequentist
performance of our methodology and to compare it with other related approaches in
literature. Section 2.4.1 compares the Bayesian P–spline approach to the frequentist
local penalty approach of Ruppert and Carroll (2000) and with a variety of recent
Bayesian approaches, in particular with the BARS (Bayesian Adaptive Regression
9Splines) method proposed by DiMatteo, Genovese and Kass (2001). Section 2.4.2
discusses the issue of the choice of knots in the implementation of our algorithm.
2.4.1 Comparison with Other Methods
We compare our Bayesian approach with the frequentist penalized splines approach
(RC, Ruppert and Carroll 2000), through the following simulation study. The X’s
were equally spaced on [0, 1], n = 400, σ2u = 0.01 and the ²i’s were Normal(0, 0.04).
First, we use the regression function as in RC whose spatial variability was controlled
by parameter j,
m(x) =
√
x(1− x) sin
[
2pi(1 + 2(9−4j)/5)
x+ 2(9−4j)/5
]
, (2.6)
where j = 3 gives low spatial variability and j = 6 gives severe spatial variability; see
Figure 1 panels (a) and (b). The fits obtained by our algorithm using a truncated
power basis function of degree 2 are shown in panels (c) and (d) along with associ-
ated 95% credible intervals. The credible intervals are estimated by computing the
respective quantiles of the sampled function evaluations.
In this chapter, we allow the smoothing/penalty parameter to be a function
of the independent variable X as in (2.3). As mentioned before, this is important
in capturing the spatial heterogeneity in the data by allowing different amounts of
smoothing in different regions. We plot the underlying penalty function, σ2(X) in
Figure 1 panels (e) and (f). We would expect the value of σ2(X) to be large if the
regression curve has rapid changes in curvature, so that the second derivative of the
fitted spline can take jumps large enough to accommodate these changes. Conversely,
if the curvature changes slowly, then we would expect σ2(X) to be small. Observe
that the penalty curve adapts to the spatial heterogeneity of the underlying regression
function with large values in the regions where the curve is non-smooth and small
10
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Figure 1. (a) Plot of the test curve used for simulations. The spatial variability
of this curve is controlled by the parameter j. In this case j=3 gives low spatial
variability. (b) j=6 gives severe spatial variability. (c) The true function with error
added. (d) Same as (c) but j = 6. (e) Plot of the estimated regression function. The
number knots (MY ) is 30 and number of subknots (Ms) is 5.(f) Same as (e) but j =
6. Here MY=90 and Ms=15. Also shown on the plots are the 95% credible intervals
on the fitted curve.
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values in smooth regions.
In order to compare the performance of fit we compute the averaged mean
squared error (AMSE), which is given by
AMSE = n−1
n∑
i=1
{m̂(xi)−m(xi)}2 . (2.7)
Our estimated AMSE for j = 3 and j = 6 is 0.0.0006 and 0.0027 respectively,
which is comparable to the those obtained by RC on the same data set, which were
0.0007 and 0.0026 respectively.
We also compared the frequentist coverage properties of the Bayesian credible
intervals with the frequentist local penalty confidence intervals of RC and with BARS.
BARS employs free-knot splines, where the number and location of knots are random,
and uses reversible jump MCMC (Green 1995) for implementation. We consider a
spatially heterogeneous regression function,
m(X) = exp{−400(X − 0.6)2}+ 5
3
exp{−500(X − 0.75)2}+ 2 exp{−500(X − 0.9)2},
(2.8)
The X’s are equally spaced on [0, 1], the sample size was n = 1000, and the ²i were
normally distributed with σ = 0.5. We use truncated power basis function of degree
2 withMY = 40 knots andMs = 4. We again set σu = 0.01. The BARS program was
graciously provided by the authors of DiMatteo et al. (2001). The BARS estimates
are based on a Poisson prior with mean 6 for the number of knots, and the MCMC
chain was run for 10,000 iterations with a burn-in period of 1000.
Figure 2 shows a typical data set with the true and fitted function plotted.
In order to compare the coverage probabilities of the Bayesian credible intervals,
we compute the frequentist coverage probabilities of the 95% credible intervals over
12
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Figure 2. A copy of simulated data for comparing coverage probabilities. Shown
are dots = data, dashed curve = true function and solid curve = Bayesian p-spline
estimate.
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500 simulated data sets. Figure 3 shows the pointwise coverage probabilities of the
95% Bayesian credible intervals along with the “adjusted” local penalty confidence
intervals of RC and those obtained by BARS. The adjustment used by RC is to
multiply the pointwise posterior variances of the local-penalty estimates by a constant
so that the average pointwise posterior variance of the estimate is the same for the
global and local penalty estimate (Ruppert and Carroll 2000, Section 4). The coverage
probabilities shown have been smoothed using P–splines to remove the Monte Carlo
variability. The average coverage probability obtained by the three methods (Bayesian
P–splines, RC, BARS) are (95.22%, 96.28%, 94.72%) respectively. The coverage
probabilities for both Bayesian P–splines and BARS are slightly closer to the nominal
coverage of 95% than the more conservative local penalty intervals of RC. Figure 4
shows the pointwise AMSE using the three methods. The average MSE for BARS
(0.0043) is somewhat smaller than the MSE for the Bayesian P-spline (0.0061) and RC
(0.0065). Thus, our results are competitive to BARS in terms of frequentist coverage
probabilities but BARS does seem to do a slightly better job than our method in
terms of overall MSE.
We also compared our method with two other Bayesian approaches, “Automatic
Bayesian Curve Fitting” method proposed by Denison, Mallick and Smith (1998a)
and the wavelet methods of Donoho and Johnstone (1994): further discussion of
some potential problems with the method of Denison, Mallick and Smith is given
by DiMatteo et al. (2001). We used the four test curves: ‘Heavisine’, ‘Blocks’,
‘Bumps’ and ‘Doppler’ as in Donoho and Johnstone . The X’s were again equally
spaced on [0, 1], n was 2048, and the ²i’s were Normal(0, 1). The values of (MY ,Ms)
are {(60, 10), (300, 30), (90, 15), (250, 80)} for Heavisine, Blocks, Bumps and Doppler
respectively. Denison et al. (1998a) reported the average MSE from 10 replications
using the above examples and compared the results with those obtained by Donoho
14
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Figure 3. Comparison of coverage probabilities. (a) Shows the frequentist cov-
erage probabilities of 95% credible intervals. The dashed line is using the adjusted
local penalty confidence interval of Ruppert and Carroll (2000) and solid line is using
the Bayesian credible intervals. The coverage probabilities shown have been smoothed
using p-splines to remove the Monte Carlo variability (b) Same as (a) for 90% cov-
erage.
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Figure 4. Comparison of pointwise mean squared errors (MSE). The dashed line
is using BARS method of (Dimatteo et al. 2001) and solid line is using the Bayesian
P-spline method. The coverage probabilities shown have been smoothed using P-splines
to remove the Monte Carlo variability.
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and Johnstone. Table 1 compares our results to those obtained by Denison et al.
(1998a) and Donoho and Johnstone . Here λ∗n is the optimal wavelet threshold chosen
specifically for each data set, while {2log(n)}1/2 is a universal threshold proposed by
Donoho and Johnstone . As noted in Denison et al. (1998a) the wavelet results
are obtained with σ2 known and, for ease of computation, require the number of
data points to be a power of 2. Specifically, we take n = 2048 and σ2u = 0.01 to
compare out results with that of Denison et al. (1998a) and Donoho and Johnstone.
Our method performs markedly better than the wavelet threshold methods in all the
examples considered. Our results are comparable with those obtained by Denison
et al. (1998a), for the ‘Heavisine’, ‘Blocks’ and ‘Bumps’ functions but is much better
for the ‘Doppler’ example.
Table 1. Average mean squared error(AMSE) comparison from 10 replications for
different example curves across different methods: wavelet threshold methods,
Automatic Bayesian curve fitting and Bayesian P-splines
Function Wavelet threshold Wavelet threshold Automatic curve Bayesian
λ∗n {2log(n)}1/2 fitting P-splines
Heavisine 0.060 0.083 0.033 0.028
Blocks 0.427 0.905 0.170 0.137
Bumps 0.499 1.080 0.167 0.098
Doppler 0.151 0.318 0.135 0.024
2.4.2 Choice of Knots
In this chapter we present a penalty approach which is similar in spirit to smoothing
splines, but with fewer knots. In P-splines the crucial parameter in controlling the
amount of smoothness is the penalty, i.e., in our case σ2(κ). Once a certain minimum
number of knots is reached, further increase in the number of knots causes little
change to the fit given by P–spline (Ruppert 2002 ; Ruppert, Wand and Carroll
2003 ). To this effect we ran an analysis with different number of knots, but the
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same selection for each method. The X’s were equally spaced on [0, 1], n = 400,
σ2u = 0.01 and the ²i’s were Normal(0, 0.04). We again use the regression function
as in (2.6) with j = 3 (low spatial variability) and j = 6 (severe spatial variability).
We used 5 different sets of knots for the regression curve and the penalty curve i.e.
{(20, 3), (40, 4), (60, 6), (90, 9), (120, 15)}. To compare the performance of fit across
the different sets of knots we compute the AMSE as in (2.7).
Table 2 shows the AMSE for the test cases described above. For j = 3 there is
essentially no improvement on the fit of the curve on increasing the number knots.
For the severe spatially variable case (j = 6) the AMSE improves appreciably by
increasing the number of knots from (20,3) to (40,4) but marginally by increasing
the knots further. In all the examples we consider, there is evidence that there is a
minimum necessary number of knots to be reached to fit the features in the data,
and a further increase in the number of knots does not have appreciable effect on
the fit. Thus, if enough knots are specified, adaptive P–splines will be able to track
the sudden changes in the underlying function, and where the underlying function is
smooth the penalty will shrink the jumps at those knots to 0.
For the penalty curve σ2(X), the number of subknots Ms is taken to be much
smaller than MY , the number of knots for the original regression spline. We tried a
variety of choices for Ms in our simulation examples and found that the choice of Ms
has relatively little effect on the fit. We keep the value of Ms large enough for the
penalty curve to be spatially variable and small enough to reduce the computational
cost. In all our simulation examples we take the value of Ms to be less than a sixth
of the number of knots chosen for original regression spline (MY ).
The variance of the error term in all the simulation examples was taken so that
we could mimic the simulation setup of the methods to which we compare our method
to. In order to study the performance of our estimator in the presence of increased
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noise we ran a further simulation study. We took the same simulation curve as in
(2.1) with j = 3, the X’s were equally spaced on [0, 1], n = 400 and σ2u = 0.01.
The variance of the error term (σ2Y ) was taken to be at three different levels: (0.04,
0.1, 0.5). The average MSE over 25 simulated datasets was found to be (0.0015,
0.0055, 0.0070) respectively showing that the fitted curve can estimate the underlying
regression function well even under increased noise.
Table 2. Average mean squared error(AMSE) comparison using different sets of
knots (MY ,Ms). Shown are the AMSE obtained for two test cases of a simulation
example curve (2.6) (see text) where j=3 gives low spatial variability and j=6 gives
severe spatial variability
Knot set j = 3 j = 6
(20,3) 0.0007 0.0094
(40,4) 0.0007 0.0048
(60,6) 0.0008 0.0036
(90,9) 0.0009 0.0028
(120,15) 0.0012 0.0027
2.5 Extension to Additive Models
2.5.1 An Algorithm for Additive Models
To this point, we have confined our attention to univariate cases only. The method-
ology developed previously can be easily extended to additive models. The general
additive model problem is to find functions mj such that
Y = α +
p∑
j=1
mj(Xj) + ², (2.9)
where the Xj are the predictor variables, E(²|X1, ..., Xp) = 0 and var(²|X1, ..., Xp) =
σ2Y . Thus the overall regression function is a sum of p univariate functions, or curve
fits. The univariate functions can be modelled with univariate splines, as we shall
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assume here. A model of the general type in (2.9) is known as an additive model.
Hastie and Tibshirani (1990) provide an extensive account of these models.
The extension to Bayesian additive models is straightforward when we use a
basis function representation (such as P-splines) for the individual curves. That is,
we can write g(X) =
∑p
j=1mj(Xj) in (2.9) as a linear combination of P-splines and
regression coefficients as:
g(X) = α0 +
p∑
j=1
α1jXj +
p∑
j=1
Mj∑
i=1
βji(Xj − κji)+, (2.10)
where again Xj is the jth predictor in X and Mj is the number of knots for the jth
curve. Each one-dimensional function is again described by the parameters βji (the
coefficients) and κji (the knots).
As in previous sections we can use the same Bayesian linear model results, to
make posterior inference for additive models. Thus the fact that a general set of
predictors is now a vector, rather than just a scalar, is of little consequence. In
matrix notation we again write
Y = Bβ + ²,
with ² ∼ Normal(0, σ2I), β = (α0, α1, . . . , αp, β1, . . . , βp)T with βj = (βj,1, . . . , βj,Mj)
and
B =

1 X1 B1,1(X1) . . . B1,M1(X1) B2,1(X1) . . . Bp,Mp(X1)
...
...
...
. . .
...
...
. . .
...
1 Xn B1,1(Xn) . . . B1,Mn(Xn) B2,1(Xn) . . . Bp,Mp(Xn)
 ,
= [1 X B1 · · · Bp]
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where
Bj =

(Xj1 − κj,1)+ . . . (Xj1 − κj,Mj)+
...
. . .
...
(Xn1 − κj,1)+ . . . (Xn1 − κj,Mj)+
 .
With the above formulation, we adopt the same methodology as discussed in the
previous sections for the univariate case. The distributional assumptions and prior
structure on the random variables and parameters respectively are exactly the same
as described in Section 2.2. The functional form of the variance of β is again a linear
regression spline as in (2.3).
2.5.2 Simulations of an Additive Model
We take a slightly modified example from Hastie and Tibshirani (1990, pp. 247–251).
We simulated from the functions m1 and m2 for the model,
Yi = m1(Xi) +m2(Zi) + ²i, i = 1, . . . , 100,
where
m1(X) =
 −2X for X < 0.6,−1.2 otherwise,
m2(Z) =
cos(5piZ)
1 + 3Z2
,
with Xi and Zi generated independently from the Uniform (0, 1) distribution and
²i from an Normal(0, 0.25) distribution. Figure 5 shows the estimates for functions
m1(X) and m2(Z), along with the credible intervals. The fits are better in terms of
AMSE than the estimates provided by Denison et al. (1998a). Also Denison et al.
(1998a) used plug-in estimates for the regression coefficients (β’s), and thus under-
estimate the uncertainty. We perform a full Bayesian analysis where in we draw the
regression coefficients from the sampler, and hence obtain standard Bayesian credible
intervals.
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Figure 5. Additive model example. The dotted line represents the true function
and the solid line represents the estimate regression function. Also shown are the 95%
credible intervals. (a) m1(X);(b) m2(Z).
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CHAPTER III
MODELING NONLINEAR GENE INTERACTIONS USING BAYESIAN MARS
3.1 Introduction
DNA microarray technology has revolutionized biological and medical research. The
use of DNA microarrays allows simultaneous monitoring of the expressions of thou-
sands of genes (Duggan et al. 1999; Schena et al. 1995), and has emerged as a tool
for disease diagnosis. This technology promises to monitor the whole genome on a
single chip so that researchers can have a better picture of the interactions among
thousands of genes simultaneously. In order to understand the biological structure
underlying the gene interactions, i.e., on what scale can we expect genes to interact
with each other, we need to model the functional structure between the genes. How-
ever, due to the complexity of the data and the curse of dimensionality, it is not an
easy task to find these structures. The purpose of this chapter is to present a statis-
tical approach to model the functional relationship between genes and also between
genes and disease status, with special focus on nonlinear relationships. In doing so,
we also identify (select), for classification purposes, the genes which are significantly
more influential than the others. In data sets that we have investigated, out method
shows equal ability to classify but uses far fewer genes to do so.
One of the key goals of microarray data is to perform classification via different
expression profiles. In principle, gene expression profiles might serve as molecular
fingerprints that would allow for accurate classification of diseases. The underly-
ing assumption is that samples from the same class share expression profile patterns
unique to their class (Yeang et al. 2001). In addition, these molecular fingerprints
might reveal newer taxonomies that previously have not been readily appreciated.
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Several studies have used microarrays to profile colon, breast and other tumors and
have demonstrated the potential power of expression profiling for classification (Alon
et al. 1999; Hedenfalk et al. 2001). Such problems can be classified as unsuper-
vised, when only the expression data are available, and supervised, when a response
measurement is also taken for each sample. In unsupervised problems (clustering)
the goal is mainly to identify distinct sets of genes with similar expression profiles,
suggesting that they may be biologically related. Both supervised and unsupervised
problems also focus on finding sets of genes that relate to different kinds of diseases,
so that future samples can be classified correctly. Classical statistical methods for
clustering and classification have been applied extensively to microarray data, see
Eisen et al. (1998) and Alizadeh et al. (2000) for clustering and Golub et al. (1999)
and Hedenfalk et al. (2001) for classification. One of the objectives of this study is
to identify sets of significant genes for classification, i.e., variable selection.
A common objective in microarray studies is to highlight genes that (on average)
co-regulate with tissue type. This can be treated within a classification framework,
where the tissue type is the response and the gene expressions are predictors. In this
chapter we will consider rule based classifiers to discover genes that co-regulate and
hence provide some of most explicit representations of the classification scheme. Rule
based classifiers use primitives such as IF A THEN B, where A relates to conditions
on the value of a set of predictors (genes) X and consequence B relates to change in
Pr(Y|X). These type of rules are easy to interpret. The best known such models
are Classification and Regression Trees (CART; Breiman et al. 1984), where decision
trees provide a graphical order of the rules. The objective of this chapter is two-fold:
(1) find significant genes of interest and (2) find the underlying nonlinear functional
form of the gene interaction. Related approaches in literature such as Lee et al.
(2003) consider only linear functions of the genes, which may not be able to model
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such complex functional forms.
In this chapter we propose to use unordered rule sets based on a Bayesian non-
parametric regression approach to model the high dimensional gene expression data.
In order to explore the complex nonlinear form of the expected responses without
knowledge about the functional form in advance, it is imperative that we look to non-
parametric techniques, since parametric models will not be flexible enough to model
these complex functions. To capture the linear dependencies, and perhaps more cru-
cially the nonlinear functional structures between the genes we use a Bayesian version
of Multivariate Adaptive Regression Splines (MARS), proposed by Friedman (1991)
and extended in the Bayesian framework (BMARS) by Denison et al. (1998b). MARS
is a popular method for flexible regression modeling of high dimensional data and has
been extended to deal with classification problems, see for example Kooperberg et al.
(1997).
In this chapter we treat the classification problem in a logistic regression frame-
work. The logistic link has a direct interpretation of the log odds of having the disease
in terms of the explanatory variables (genes). Since our model space is very large,
i.e. with p genes we have 2p models, exhaustive computation over this model space
is not possible. Hence Markov Chain Monte Carlo (MCMC; Gilks et al. 1996) based
stochastic search algorithms are used. Our approach is to identify significant set(s)
of genes over this vast model space, first to classify accurately and then to model
the functional relationship between them. The flexible nonparametric setup creates
a powerful predictive model, but unlike many black box predictive machines, our
method identifies the significant genes as well as focuses on the interactions among
them. In this sense, the method has the advantage that it combines scientific inter-
pretation with accurate prediction.
In order to illustrate our methodology, we choose as examples two publicly avail-
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able data sets: Leukemia Data (Golub et al. 1999) and Hereditary Breast Cancer
data (Hedenfalk et al. 2001). For each case we find sets of genes that have discrimi-
nating power. We also find the functional form of the main effect of dominant genes
and the interaction function between genes that have significant interactions.
3.2 Model Formulation
For a binary class problem the response is usually coded as Yi = 1 for class 1 and
Yi = 0 for the other class, where i = 1, . . . , n and where n is the number of samples
(arrays). Gene expression data for p genes for n samples is summarized in an n × p
matrix, X, where each element xij denote the expression level (gene-expression value)
of the jth gene in the ith sample where j = 1, . . . , p. The exact meaning of expression
values may be different for different matrices, representing absolute or comparative
measurements, see Brazma et al. (2001). Our objective is to use the training data
Y = (Y1, . . . , Yn)
T to estimate p(X) = Pr(Y = 1|X) or alternatively the logit function
f(X) = log[p(X)/(1− p(X))].
Assume that the Yi’s are independent Bernoulli random variables with Pr(Yi =
1) = pi so that, p(Yi|pi) = pYii (1 − pi)1−Yi . We construct a hierarchical Bayesian
model for classification as thus. Writing pi = exp(ωi)/[1 + exp(ωi)], wherein ωi’s are
the latent variables introduced in the model to make Yi’s conditionally independent
given the ωi’s. We relate ωi to f(Xi) as,
ωi = f(Xi) + ²i, (3.1)
whereXi is the ith row of the gene expression data matrixX (vector of gene expression
levels of the ith sample) and ²i are residual random effects. The residual random
effects account for the unexplained sources of variation in the data, most probably
due to explanatory variables (genes) not included in the study.
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We choose to model f in nonparametric framework, primarily due to the fact that
parametric approaches are not flexible enough to model such “rich” gene expression
datasets. One of the most common choices for f is to use a basis function method of
the form,
f(Xi) =
k∑
i=1
βjB(Xi, θj),
where β are the regression coefficients for the bases B(Xi, θj), which are non-linear
functions of Xi and θ. Examples of basis function include regression splines, wavelets,
artificial neural networks and radial bases. We choose a MARS basis function pro-
posed by Friedman (1991) to model f as,
f(xi) = β0 +
k∑
j=1
βj
zj∏
l=1
(xidjl − θjl)qjl , (3.2)
where k is the number of spline basis, β = {β1, . . . , βk} are the set of spline coefficients
(or output weights), zj is the interaction level (or order) of the jth spline, θjl is a
spline knot point, djl indicates which of the p predictors (genes) enters into the lth
interaction of the jth spline, djl ∈ {1, . . . , p}, and qjl determines the orientation of
the spline components, qjl ∈ {+,−} where (a)+ = max(a, 0), (a)− = min(a, 0). We
choose the MARS basis function as it can flexibly model the functional relationship
between explanatory variables (genes) and gives interpretable models as compared to
black box techniques such as artificial neural networks.
We illustrate this rather complex notation (3.2) through an example. Suppose a
MARS model is of the following form (dropping the subscript i),
f = 2.5 + 3.2(x20 − 2.5)+ + 4.1(x10 − 1.2)−(x30 + 3.4)+
Here we have k = 2 spline basis functions with β = {2.5, 3.2, 4.1} as the spline
coefficients. Gene 20 enters the model as a linear term (main effect) with interaction
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level z1 = 1, knot point θ11 = 2.5, spline orientation q11 = +. We observe a bivariate
interaction between genes 10 and 30 i.e. d21 = 10, d22 = 30 with corresponding
knots = (1.2,−3.4) and spline orientation = (−,+). See Friedman (1991) for a
comprehensive illustration of the model.
Write (3.1) and (3.2) in matrix form as,
ω = Θβ + ², (3.3)
where ω is the vector of the latent variables, and Θ is the MARS basis matrix,
Θ =

1
∏z1
l=1(x1d1l − θ1l)q1l · · ·
∏zk
l=1(x1dkl − θkl)qkl
1
∏z1
l=1(x2d1l − θ1l)q1l · · ·
∏zk
l=1(x2dkl − θkl)qkl
...
...
. . .
...
1
∏z1
l=1(xnd1l − θ1l)q1l · · ·
∏zk
l=1(xndkl − θkl)qkl

(3.4)
In order to aid a Bayesian formulation we impose a prior structure on all the
model parameters, M = {β,θ, q,d,z, v, k, ,λ, σ2}. The specific forms of the priors
that we take are as follows. We assign a Gaussian prior to β with mean 0 and variance
σ2D−1, where D ≡ diag(λ1, λ, . . . , λ) is (n + 1) × (n + 1) diagonal matrix. We fix
λ1 to a small value, amounting to a large variance for the intercept term but keep
λ unknown. We assign a Inverse-Gamma(IG) prior to σ2 and a gamma prior to λ
with parameters (γ1, γ2) and (τ1, τ2) respectively. Note that the above model can be
extended to have multiple prior variances on β as,
p(β, σ) ∼ Nn+1(β|0, σ2D−1)IG(σ2|γ1, γ2)
whereD is a diagonal matrix with diagonal elements λ = (λ1, . . . , λn+1)
T . Once again
λ1 is fixed to a small value but all other λ’s are unknown. We assign independent
Gamma (τ1, τ2) priors to them.
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The prior structure on the MARS model parameters are as follows. The prior
on the individual knot selections θjl is taken to be uniform over the n data points
p(θjl|djl) = U(x1djl , x2djl , . . . , xndjl), where djl indicates which of the genes enter our
model and p(djl) is uniform over the p genes, p(djl) = U(1, . . . , p). The prior on
the orientation of the spline is again uniform, p(qjl = +) = p(qjl = −) = 0.5. The
interaction level in each spline has a prior, p(zj) = U(1, . . . , zmax), where zmax is the
maximum level of interaction set by the user. Finally the prior on k, the number of
splines, is taken to an improper one, p(k) = U(1, . . . ,∞), which indicates no a priori
knowledge on the number of splines. Hence the model now has only one user defined
parameter, zmax, the maximum level of interaction, for which we shall recommend a
default setting in Section 3.5.
3.3 Computation
The information from the data are combined with the prior distributions on the
parameters via Bayes’ theorem and the likelihood function as,
p(ω,θ, q,d,z,β, v, k,λ, σ2|Y) = p(Y|ω,θ, q,d, z,β, v, k,λ, σ2)
×p(ω,θ, q,d,z,β, v, k,λ, σ2)
For classification problems with binary data and logistic likelihood, conjugate priors
do not exist for the regression coefficients. With the Bayesian hierarchical structure
as in the previous section the posterior distributions are not available in explicit form,
so we use MCMC techniques (Gilks et al. 1996) for inference. Conventional MCMC
methods such as the Metropolis-Hastings (MH) algorithm (Metropolis et al. 1953;
Hastings 1970) are not applicable here since the parameter (model) space is variable:
we do not know the number of splines apriori. Hence we use the variable dimension
reversible jump algorithm outlined in Green (1995).
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In our framework, the chain in updated using the following proposals with equal
probability:
1. Add a new spline basis to the model.
2. Remove one of the k existing spline bases from the model.
3. Alter an existing spline basis in the model (by changing the knot points).
Following each move an update is made to the spline coefficients β. Note that the
above three move steps are equivalent to adding, removing and altering a column of
Θ in (3.4). The algorithm is included in the Appendix B. The update to β is the
critical step determining the efficiency of the algorithm. A poor proposal distribution
for β results in the current state having low posterior probabilities and low acceptance
rates. This is because adding, deleting or altering a column of Θ in (3.4) would alter
the remaining β parameters as they are now ill-tuned to the data.
We introduce the latent variables ω to circumvent the problem. The idea is to
introduce an extra set of parameters into the model that leave the original (mar-
ginal) model distribution unchanged, in order to improve the overall efficiency of
the sampling algorithms. Therefore conditional on ω, all the other parameters are
independent of Y. This allows us to adopt conjugate priors for (β, σ2) to perform
the MCMC calculations as well as marginalize over the model space. Considerable
computational advantage is gained from the fact that the posterior distribution of
β given the other parameters is now known exactly, i.e., normally distributed. The
details of the procedure are given in Appendix .
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3.4 Prediction and Model Choice
For a new sample with gene expression xnew, the marginal posterior distribution of
the new disease state, ynew is given by
Pr(ynew = 1|xnew) =
∞∑
k=1
∫
P (ynew = 1|xnew,Mk)P (Mk|Y )dMk, (3.5)
where Pr(Mk|Y ) is the posterior probability andMk indicates the MARS model with
k splines. The integral given in (3.5) is computationally and analytically intractable
and needs approximate procedures. We approximate (3.5) by its Monte Carlo estimate
by,
Pr(ynew = 1|xnew) = 1
m
m∑
j=1
P (ynew = 1|xnew,M(j)), (3.6)
whereM(j) for j = 1, . . . ,m are the m MCMC posterior samples of the MARS model
parametersM. The approximation (3.6) converges to the true value (3.5) as m→∞.
In order to select from different models, we generally use misclassification error.
When a test set is provided, we first obtain the posterior distribution of the parameters
based on training data, ytrn (train the model) and use them to classify the test
samples. For a new observation from the test set, yi,test we will obtain the probability
Pr(yi,test = 1|ytrn, xi,test) by using the approximation to (3.5) given by (3.6). When
this probability is greater than 0.5 we will classify it as 1 and when it is less than
0.5 we will classify it as 0. The number of misclassified samples from the test set is
defined as the misclassification error.
If there is no test set available, we will use a hold-one-out cross-validation ap-
proach. For the cross validation predictive density, in general, let Y−i be the vector
of Yj’s without the ith observation Yi,
P (Yi|Y−i) = P (Y)P (Y−i) =
[∫ {P (yi|Y−i,Mk)}−1P (Mk|Y)dMk]−1 .
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The MCMC approximation to this is
P̂ (Yi|Y−i,trn) = m−1
m∑
j=1
{
P (yi|Y−i,trn,M(j))
}−1
,
whereM(j) for j = 1, . . . ,m are the m MCMC posterior samples of the MARS model
parametersM. This simple expression is due to the fact that the Yi’s are conditionally
independent given the model parameters M.
3.5 Examples
We illustrate the Bayesian methodology with two microarray examples. For all the
examples considered below we set the maximum level of interaction, zmax = 2, i.e.,
allow for only additive and bivariate interactions. The MCMC chain is run for 50,000
iterations of which the first 10,000 are discarded as burn-in.
3.5.1 Leukemia Data
This microarray data set is taken from Golub et al. (1999). The data set contains
measurements corresponding to samples from Bone Marrow and Peripheral blood
samples taken from 72 patients with either acute lymphoblastic leukemia (ALL) or
acute myeloid leukemia (AML). As in the original paper we split the data into a
training set of 38 samples (27 are ALL and 11 AML) and a test set of 34 samples
(20 ALL and 14 AML). The data set contains expression levels for 7129 human genes
produced by Affymetrix high-density oligonucleotide microarrays.
In order to identify significant genes, we isolate those genes that enter our MARS
model most frequently in the posterior samples. Table 3 shows the genes that occur
most frequently as main effects in our model. The other genes’ main effects were not
observed frequently in the generated MCMC samples so did not have great influence
on the response. The corresponding plots of the posterior mean main effect functions
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Table 3. Leukemia data: Top 50 genes (predictors) entering the Bayesian MARS
model as main effects ranked in descending order of the frequency of times they
appear in posterior MCMC samples
Gene ID Gene description Frequency
X95735 Zyxin 1.206
J04615 SNRPN Small nuclear ribonucleoprotein polypeptide N 1.018
M62762 ATP6C Vacuolar H+ ATPase proton channel subunit 0.888
J04027 Adenosine triphosphatase mRNA 0.752
X64364 BSG Basigin 0.388
Z11793 Selenoprotein P 0.354
U29091 GB DEF = Selenium-binding protein (hSBP) mRNA 0.352
U26710 Cbl-b mRNA 0.32
Z17240 HMG2 High-mobility group (nonhistone chromosomal) protein 2 0.32
L00058 MYC V-myc avian myelocytomatosis viral oncogene homolog 0.266
U79285 GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE 0.19
X62320 GRN Granulin 0.186
U10323 Nuclear factor NF45 mRNA 0.18
M80254 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE 0.172
HG2280-HT2376 D-Amino-Acid Oxidase 0.172
M15059 ”FCER2 Fc fragment of IgE, low affinity II, receptor for (CD23A)” 0.166
L07956 ”GBE1 Glucan (1,4-alpha-), branching enzyme 1 (glycogen branching enzyme,
Andersen disease, glycogen storage disease type IV)” 0.146
U02388 ”LTB4H Leukotriene B4 omega hydroxylase (cytochrome P450, subfamily IVF)” 0.14
M19888 SPRR1B Small proline-rich protein 1B (cornifin) 0.138
M15841 SNRPB2 Small nuclear ribonucleoprotein polypeptide B” 0.138
X66363 SERINE/THREONINE-PROTEIN KINASE PCTAIRE-1 0.124
U90919 Clones 23667 and 23775 zinc finger protein mRNA 0.122
S73885 TFAP4 Transcription factor AP-4 (activating enhancer-binding protein 4)) 0.118
Y12812 RFXAP mRNA 0.112
U97188 Putative RNA binding protein KOC (koc) mRNA 0.104
U82759 GB DEF = Homeodomain protein HoxA9 mRNA 0.086
X59417 PROTEASOME IOTA CHAIN 0.084
U61849 NPTX1 Neuronal pentraxin I 0.082
HG2604-HT2700 Pan-2 0.082
X60655 EVX1 Even-skipped homeo box 1 (homolog of Drosophila) 0.082
X59131 D13S106 mRNA for a highly charged amino acid sequene 0.08
L40400 ”(clone zap113) mRNA, 3’ end of cds” 0.08
Z33642 V7 mRNA for leukocyte surface protein 0.08
X74570 Gal-beta(1-3/1-4)GlcNAc alpha-2.3-sialyltransferase 0.078
M64571 MAP4 Microtubule-associated protein 4 0.078
X99585 SMT3B protein 0.076
L40393 (clone S171) mRNA 0.074
L12760 ”PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC” 0.072
L00022 IG EPSILON CHAIN C REGION 0.07
J00209 ”IFNA10 Interferon, alpha 10” 0.066
U93205 Nuclear chloride ion channel protein (NCC27) mRNA 0.062
D63880 KIAA0159 gene 0.06
L36818 INPPL1 Inositol polyphosphate phosphatase-like protein 1 (51C protein) 0.06
HG2743-HT2846 ”Caldesmon 1, Alt. Splice 4, Non-Muscle” 0.06
X92110 HcgVIII protein 0.06
X05997 GB DEF = Gastric lipase 0.058
HG4185-HT4455 ”Estrogen Sulfotransferase, Ste” 0.058
L78132 Prostate carcinoma tumor antigen (pcta-1) mRNA 0.058
L40586 IDS Iduronate 2-sulfatase (Hunter syndrome) 0.056
D26067 ”KIAA0033 gene, partial cds” 0.056
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is shown in Figure 6. These curves are estimated by,
E{fi(X)} = 1
T
T∑
t=1
∑
j:zj=1
djl=i
β
(t)
j Θ
(t)
j (X), (3.7)
where T is the number of models in the generated sample, indexed with the super-
script. The second summation ensures that the curves are estimated by only consid-
ering the main effect basis functions involving the i gene (predictor), thus averaging
over the basis functions relating to the desired gene main effect. Note here that these
curves can only guide us to the shape of the main effect functions. We can see that
there is evidence that gene BSG Basigin shows little effect on the response. As the
expression level of gene Adenosine triphosphatase mRNA increases the response de-
creases linearly. Observing the plots of main effect functions (Figure 6), for the gene
Zyxin the response is unaffected over the negative expression values but decreases
linearly for increasing positive expression values, while on the other hand exactly the
opposite feature is found gene SNRPN Small nuclear ribonucleoprotein polypeptide
N where the response increases linearly for negative expression values and is unaf-
fected in the positive range. Similar conclusions can be drawn for other genes too.
This demonstrates how threshold basis functions such as MARS, allow for insightful
interpretation of the relationship between response and genes (predictors), with the
added advantage being that MARS model automatically ignores variables that have
little effect on the response.
Table 4 shows the genes that enter as an interaction term most often in the
posterior samples. Figure 7 shows the interaction surface of the top three interact-
ing gene pairs indicating the joint contribution to the odds of having a disease of
the two genes. The surface is estimated in a manner similar to (3.7), but now we
only consider interaction terms involving the two genes desired in the second sum-
mation. This figure highlights the advantage of the using flexible nonlinear MARS
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Figure 6. Leukemia data: Posterior mean main effects of the significant genes
entering the Bayesian MARS model. The horizontal axis is the standardized expres-
sion level of the gene and the vertical axis is the mean main effect function.
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basis functions in discerning this complex interaction function between genes over
linear approaches. In the top panel of Figure 7 we can see that high expression levels
of gene Alpha-Amylase 2B Precursor combined with low (negative) expression levels
of gene Adenosine triphosphatase calcium results in an increased level of response,
which is unaffected for low levels of both genes. A similar feature is also detected
observing the interaction surface of genes Natural killer cell receptor (KIR) mRNA
and HOXA1 Homeo box A1. From the bottom most panel we can observe that the
odds increases as the expression level of gene LYN V-yes-1 Yamaguchi sarcoma viral
related oncogene homolog increases and that of gene DAGK1 Diacylglycerol kinase
alpha decreases.
Using two pairs of genes that discriminate between the two classes AML and ALL
reasonably, we plot the probability contours, Pr(Yi = 1) (Figure 8) to demonstrate
the advantages of using a nonlinear model. Any linear approach would divide the
predictor space into two regions separated by a straight line. Such a complex decision
boundary can only be uncovered using a nonlinear model. Note that this predictive
contours appear smooth even though individual MARS models have axis parallel
non-smooth contours. This is due to averaging over thousands of MARS models,
thus marginalizing over the model space.
Golub et al. use a 50-gene predictor trained using their weighted voting scheme
on the training samples. The predictor made strong predictions for 29 of the 34 test
samples, declining to predict the other five cases. For the same case our misclassifica-
tion error rate for the test set is 0.08, i.e, we misclassify 3 out of the 34 test samples.
Our results appear to be competitive to the results from Golub et al., but we use
far fewer genes. Figure 9(a) shows the marginal density of the number of splines,
p(k|Y ) from 50,000 samples of our MCMC chain. The mode of the distribution is 2
basis terms, thus showing that we get competitive results by using considerably fewer
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Figure 7. Leukemia data: Posterior mean interaction functions of the significant
genes entering the Bayesian MARS model. The X and Y axes are the standardized
expression levels of the interacting genes and the vertical axis is the mean interaction
function.
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genes.
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Figure 9. Plot of p(k|Y ), the posterior distribution of the number of splines
basis functions using 50,000 samples from the MCMC output. (a) Leukemia data; (b)
Breast cancer data.
3.5.2 Hereditary Breast Cancer Data
We use the microarray data-set used in Hedenfalk et al. (2001) on breast tumors from
patients carrying mutations in the predisposing genes, BRCA1 or BRCA2 or from
patients not expected to carry a hereditary predisposing mutation. Pathological and
genetic differences appear to imply different but overlapping functions for BRCA1 and
BRCA2. They examined 22 breast tumor samples from 21 breast cancer patients, and
all patients except one were women. Fifteen women had hereditary breast cancer, 7
tumors with BRCA1 and 8 tumors with BRCA2. 3,226 genes were used for each breast
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tumor sample. We use our method to classify BRCA1 versus the others (BRCA2 and
sporadic).
Table 5 lists the top 50 genes that enter as main effects in the MARS model
in posterior MCMC samples, along with the corresponding frequency of appearance.
Similarly Table 6 shows the top 25 interacting genes that enter the MARS model.
These genes enter our model most frequently while classifying BRCA1 versus BRCA2
and sporadic. A similar list of 51 genes which best differentiate among the types of
tumor is also provided by Hedenfalk et al.. We find quote a few overlapping genes
(marked by a *) between the two lists like keratin 8 (KRT8), ODCantizyme and
ACTR1A. KRT8 is a member of the cytokeratin family of genes and cytokeratins are
frequently used to indentify breast cancer metastases by immunohistochemistry, and
cytokeratin 8 abundance has been shown to correlate well with node-positive disease
(Brotherick et al. 1998).
Figure 10 shows the posterior mean main effect function of the top six genes genes
selected from the list. The vertical axis show the odds of having BRCA1 mutation
and the horizontal axis is the standardized expression level of that particular gene.
An advantage of using a nonlinear approach is evident here as we can unearth a
threshold expression level and its corresponding effect on the the odds of having a
BRCA1 mutation. For example, for polymerase (RNA) II polypeptide it is seen that
the odds are relatively high for negative expression levels while the odds decrease
for higher expression levels of the gene. Figure 11 shows posterior mean interaction
function of two pairs of genes from the list of top 25. This shows the combined effect
these two genes on the odds of carrying mutation of BRCA1.
Since test data were not provided, to check our model adequacy we used full
hold-one-out cross validation. The results are summarized in Table 7. We compare
our cross validation results with other popular classification algorithms as in Lee et
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Table 5. Breast cancer data: Top 50 genes (predictors) entering the Bayesian
MARS model as main effects ranked in descending order of the frequency of times
they appear in posterior MCMC samples
Image Clone ID Gene description Frequency
767817 polymerase (RNA) II (DNA directed) polypeptide F 3.596
307843 ESTs (*) 2.87
81331 ”FATTY ACID-BINDING PROTEIN, EPIDERMAL” 2.46
843076 signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 2.396
825478 zinc finger protein 146 2.304
28012 O-linked N-acetylglucosamine (GlcNAc) transferase 2.17
812227 ”solute carrier family 9 (sodium/hydrogen exchanger), isoform 1 ” 2.024
566887 heterochromatin-like protein 1 (*) 1.946
841617 ornithine decarboxylase antizyme 1 (*) 1.894
788721 KIAA0090 protein 1.81
811930 KIAA0020 gene product 1.668
32790 ”mutS (E. coli) homolog 2 (colon cancer, nonpolyposis type 1)” 1.46
784830 D123 gene product (*) 1.396
949932 nuclease sensitive element binding protein 1 (*) 1.382
26184 ”phosphofructokinase, platelet” (*) 1.294
810899 CDC28 protein kinase 1 1.294
46019 minichromosome maintenance deficient (S. cerevisiae) 7 (*) 1.266
897781 keratin 8 (*) 1.192
32231 KIAA0246 protein (*) 1.084
293104 phytanoyl-CoA hydroxylase (Refsum disease) (*) 1.006
180298 protein tyrosine kinase 2 beta 0.952
47884 macrophage migration inhibitory factor (glycosylation-inhibiting factor) 0.864
137638 ESTs (*) 0.792
246749 ”ESTs, Weakly similar to trg [R.norvegicus]” 0.792
233365 HP1-BP74 0.788
815530 PAK-interacting exchange factor beta 0.68
123425 ”ESTs, Moderately similar to AF141326 RNA helicase HDB/DICE1 [H.sapiens]” 0.642
22230 ”collagen, type V, alpha 1” 0.612
324210 sigma receptor (SR31747 binding protein 1) 0.608
824117 vaccinia related kinase 2 0.602
124405 androgen induced protein 0.594
83210 ”Complement component 8, beta polypeptide” 0.592
49788 carnitine acetyltransferase 0.59
344352 ESTs 0.586
842806 cyclin-dependent kinase 4 0.568
810734 Human 1.1 kb mRNA upregulated in retinoic acid treated HL-60 neutrophilic cells 0.564
814701 ”MAD2 (mitotic arrest deficient, yeast, homolog)-like 1” 0.554
36007 zinc finger protein 133 (clone pHZ-13) 0.518
110503 FOS-like antigen-1 0.492
767784 jun D proto-oncogene 0.488
486844 ”gap junction protein, alpha 1, 43kD (connexin 43)” 0.486
810408 hypothetical 43.2 Kd protein 0.456
199381 vav 3 oncogene 0.446
509682 histone deacetylase 3 0.446
43021 histidyl-tRNA synthetase 0.438
212198 ”tumor protein p53-binding protein, 2” (*) 0.418
840702 SELENOPHOSPHATE SYNTHETASE ; Human selenium donor protein (*) 0.402
666128 D component of complement (adipsin) 0.4
613126 ubiquitin specific protease 13 (isopeptidase T-3) 0.396
139705 ESTs 0.384

43
−0.5 0 0.5 1
0
0.5
1
F(
x)
(a) O−linked GlcNAc transferase 
−1 −0.5 0 0.5 1
0.2
0.4
0.6
0.8
1
F(
x)
(b)  zinc finger protein 146
−0.5 0 0.5 1
0
0.1
0.2
0.3
0.4
F(
x)
(c) signal transducing adaptor molecule 
−0.5 0 0.5 1 1.5 2
0.6
0.7
0.8
0.9
1
F(
x)
 (d) Fatty Acid−Binding Protien, Epidermal
−0.5 0 0.5 1 1.5
0.2
0.4
0.6
0.8
1
F(
x)
(e) ESTs
−1 −0.5 0 0.5 1
0
0.5
1
F(
x)
(f) polymerase (RNA) II polypeptide 
Figure 10. Breast cancer data: Posterior mean main effects of the significant
genes entering the Bayesian MARS model. The horizontal axis is the standardized
expression level of the gene and the vertical axis is the mean main effect function.
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al. (2003). All the other methods use 51 genes for classification purposes while the
MARS methods selects far fewer genes. Figure 9(b) shows the marginal density of
the number of splines, p(k|Y ) from 50,000 samples of our MCMC chain. The mode
of the distribution is 3 showing that the number of splines basis terms (genes) used
by the model adapts to the problem at hand and uses fewer genes with the results
being competitive to any other method.
Table 7. Model misclassification errors using hold-one-out cross-validation for
breast cancer data
Model Number of
misclassifies samples
Bayesian MARS 0
Feed-forward neural networks 1.5 (Average error)
(3 hidden neurons, 1 hidden layer)
Gaussian kernel 1
Epanechnikov kernel 1
Moving window kernel 2
Probabilistic neural network (r=0.01) 3
kNN (k=1) 4
SVM linear 4
Perceptron 5
SVM Nonlinear 6
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CHAPTER IV
SUMMARY AND FUTURE RESEARCH
In Chapter II we presented an automated Bayesian method to fit spatially adaptive
curves. We also provided an extension to additive models, wherein we obtained
estimates of regression function and uncertainty intervals. We use regression P-splines
to model the unknown smooth function, but we allow spatial adaptivity in the penalty
function by modeling it as another regression P–spline. Our simulations indicate that
our method is very competitive to that of Ruppert and Carroll (2000) in terms of
frequentist mean squared error and coverage probabilities of the credible intervals.
We also provide Bayesian uncertainty intervals: the intervals had pointwise coverage
close to the frequentist nominal level. Other methods, such as those of Donoho and
Johnstone (1994) and Denison et al. (1998a) appear to be no better than ours, and
in some cases worse. Simulations indicate that our methods are roughly comparable
to the BARS method of DiMatteo et al. (2001).
One issue that remains unresolved is choice of the number of knots for the re-
gression P-spline. We have here relied on the work of Ruppert (2002) in simulated
data sets, the analyses of data examples in Ruppert et al. (2003), and work of Eil-
ers and Marx (1996, 2002) as evidence that a large number of knots is unnecessary
within the P-spline paradigm, with recommendations of between 10 and 50 knots
for most situations of non-spatially adaptive smoothing. We believe that choosing
a far smaller number of knots for spatially adaptive smoothing, as we have done,
makes intuitive sense, and clearly works well in our examples, and in the examples
of Ruppert and Carroll (2000). Inevitably, however, there will be interest in letting
the data select the number of knots, even in the P-spline paradigm. Indeed, this has
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been done in the frequentist approach, see Ruppert and Carroll (2000) and Ruppert
et al. (2003, Chapter 17), where the number of knots and subknots is effectively
chosen by GCV. We conjecture that the following method will work in our Bayesian
context: it is based on the work of Kass and Wasserman (1995) and illustrated in
a model-averaging context by Carroll, Roeder and Wasserman (1999). Specifically,
choose a set of numbers of knots and subknots: Ruppert, et al. use combinations of
(10, 20, 40, 80, 120) for the former and (3, 4, 5, 6) for the latter. Then run our method
for each of the combinations, and compute BIC for each at the posterior mean of
median of the parameters. Finally, either select the combination on the basis of BIC,
or average the fits using BIC as a model averaging device. We conjecture that this
approach will work comparably to the frequentist approaches.
The other obvious issue here is the general comparison between regression spline
methods. There are basically three approaches: (a) the P-spline approach as advo-
cated here needs little more introduction; (b) knot selection methods such as BARS;
and (c) regression splines without penalization but where the number of knots are
selected using devices such as BIC and AIC, see Rice and Wu (2001) for an illus-
tration. All these methods have value. Approach (c) generally tends to choose a
smallish number of knots and is essentially only available in a frequentist context.
Our own view is that in the frequentist context of regression splines, penalization
with a fixed number of knots is a more natural approach than selecting the number of
knots, especially when inference is of interest, since inference after model selection is
extremely difficult in the frequentist context. The knot selection methods (free-knot
splines) are clearly geared to handle problems where a high degree of spatial adapta-
tion is necessary: that the P-spline approach does reasonably well in comparison to
say BARS may in fact be seen as somewhat surprising. One nice feature of P-splines
is that being little more than mixed models methods, they are readily adapted to
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new problems without great effort. Ciprian Crainiceanu (personal communication)
has recently shown how to implement our methods in WinBUGS, which gives some
sense of its ease of application.
An interesting question concerns extension of these methods to non-Gaussian
data. Indeed, BARS for example was motivated originally for the treatment of Pois-
son data, where it is extremely effective. Bayesian versions of penalized regression
splines that are not spatially adaptive are easy to develop for generalized linear mod-
els, either via brute-force (Ruppert, et al., 2003, Chapter 16) or via latent variable
methods such as those Albert and Chib (1993) for binary data, and of Holmes and
Mallick (2003) for binary and count data as special cases. These latter approaches
essentially place one back into the Gaussian framework after the latent variables are
computed, and these devices should allow spatially adaptive smoothing to be devel-
oped readily. Another interesting question is spatially adaptive smoothing in the
presence of heteroscedasticity: frequentist P-splines are readily developed in this case
(Ruppert, et al., 2003, chap. 14), and adding Bayesian spatially adaptive smoothing
should be possible.
In Chapter II we presented a approach to model nonlinear gene interactions using
a Bayesian MARS. Our method uses MCMC based stochastic search algorithms to
obtain the models. The advantage of our method is that we capture the nonlinear
dependencies between the genes, dependencies that would have been missed by linear
approaches. Our approach is not only flexible enough to model these complex interac-
tion functions, but it also identifies significant genes of interest for further biological
study. We illustrated our method using two microarray data sets which have been
well analyzed in literature. In both cases we used far fewer genes and yet obtained
competitive results to those reported in literature.
We have treated the binary case in detail in this study. When the response is
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not binary, such that the number of classes (C) is greater than two, then the problem
becomes a multiclass classification problem. This can be handled in a manner similar
to the binary classification approach, as follows. Let Yi = (Yi1, . . . , YiC) denote the
multinomial indicator vector with elements Yiq = 1 if the qth sample is belongs to the
qth class and Yij = 0 otherwise. Let Y denote the n× C matrix of these indicators.
The likelihood of the data given the MARS spline bases (Θ1, . . . ,ΘC), is given by,
P(Yi = 1|Xi) = pyi11 pyi22 , . . . , pyiCC ,
where pq is the probability that the sample came from class q. This is modelled in a
similar manner to the binary class case as in Section 3.2. The prior structure imposed
on the parameters is also akin to that described in Section 3.2. A detailed study will
be performed in future.
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APPENDIX A
BAYESIAN P–SPLINES: DETAILS OF THE SAMPLER
In this section we derive the conditional distributions for the all the random variables
and parameters in the spatially adaptive Bayesian P–spline model outlined in Chapter
II. The algorithm for the MCMC sampling is as follows:
• Give initial values to all parameters: ΩY , Ωs, ξ2, {σ2(κj)}MYj=1 and σ2Y .
• Start the MCMC sampler and iterate.
• Updating (ΩY , σ2Y )
Conditional on the rest of the parameters, using Bayesian linear model theory
with conjugate priors, the conditional posterior distribution of (ΩY , σ
2
Y ) is,
[ΩY , σ
2
Y ] ∼ Normal(mY ,ΣY )IG(a˜Y , b˜Y )
where mY = (1/σ
2
Y )(ΣYZ
T
Y Y ), ΣY = [(Z
T
Y ZY /σ
2
Y +Λ
−1
Y )
−1], ZY is the regression
spline design matrix and ΛY = diag{100, . . . , 100, σ2(κ1), . . . , σ2(κMY )} is the
prior variance on ΩY . Here IG(•) is the Inverse Gamma distribution with
shape parameter, a˜Y = [(n/2) + aY ] and scale parameter, b˜Y = [(1/2){(Y −
ZYΩY )
T (Y − ZYΩY )}+ (1/bY )]−1.
• Updating (Ωs, ξ2)
With conjugate priors on (Ωs, ξ
2), the conditional posterior distribution is,
[Ωs, ξ
2] ∼ Normal(ms,Σs)IG(a˜s, b˜s)
where ms = (1/σ
2
u)(ΣsZ
T
s ρ), Σs = [(1/σ
2
u)(Z
T
s Zs) + Λ
−1
s ]
−1 and ρ denotes the
vector [− log{σ2(κ1)}, . . . ,− log{σ2(κMY )}]T . Λs = diag{100, 100, ξ2, . . . , ξ2} is
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the prior variance on Ωs. The posterior inverse gamma parameters are a˜s =
[(MY /2)+as] and b˜s = [(1/2){
∑Ms
j=1 β
2
js}+(1/bs)]−1. We set (as, bs) to be (1, 1)
for all the examples.
• Updating {σ2(κj)}MYj=1
The penalty parameters, {σ2(κj)}MYj=1, conditional on the current model para-
meters does not have an explicit form. Thus we resort to Metropolis-Hastings
procedure withe a proposal density T [σ2∗(κj), σ2(κj)] that generates the moves
from the current state σ2∗(κj) to a new state σ2(κj). The proposed updates are
then accepted with probabilities,
α = min
{
1,
p[σ2∗(κj)|rest]T [σ2(κj), σ2∗(κj)]
p[σ2(κj)|rest]T [σ2∗(κj), σ2(κj)]
}
,
otherwise the current model is retained. It is convenient to take the proposal
distribution T [σ2∗(κj), σ2(κj)] to be a symmetric distribution (eg. Gaussian)
with mean equal to the old value σ2(κj) and a pre-specified standard deviation.
Since the density involves exponential terms, the likelihood values
calculated during the implementation of the algorithm are typically very large,
hence we worked on a log scale. A common problem encountered in the imple-
mentation is the non-mobility of the MH step. If we start at bad starting values
it may take a large number of iterations or even worse may not converge. To
circumvent the problem we use frequentist estimates as starting values for the
MCMC run, and in particular use the estimates of the smoothing parameter
that minimize the generalized cross validation (GCV) statistic
GCV =
‖Y − ZYΩY (σ2(κ))‖
[(1− df(σ2(κ)))/n]2
where
df(σ2(κ)) = tr{(ZTY ZY + ΛY )−1(ZTY ZY )}
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is the degree of freedom of the smoother which is defined to be the trace of the
smoother matrix (Hastie and Tibshirani, 1990 Section 3.5).
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APPENDIX B
BAYESIAN MARS: DETAILS OF THE SAMPLER
In this section we derive the conditional distributions for the all the random variables
and parameters in the Bayesian MARS model outlined in Chapter III. The algorithm
for the MCMC sampling is as follows:
• Start with an constant intercept model with k = 0 and Θ = (1, . . . , 1)′.
• Set the initial values of the latent variables ω.
• Draw the intercept (β0, σ2) using the update for (β, σ2) as given below.
• Start the MCMC sampler and iterate.
– Draw latent variable ω given the current model.
– Update prior precision λ on β as given below.
– Update Θ using one of the following moves with equal probability.
∗ Add a spline basis function.
∗ Delete a spline basis function.
∗ Alter a spline basis function.
– Redraw (β, σ2)
– Accept the modifications to Θ and β with probability,
Q = min
{
1,
|V̂ ∗|1/2
|V̂ |1/2 exp
( a
a∗
)}
where |V̂ | is the determinant of the posterior variance covariance matrix of
β and is given by (Θ′Θ +D)−1, the superscript ∗ refer to the parameters
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of the proposed update model and a is the error term,
a = ω′ω − β̂′V̂ −1β̂.
– Otherwise keep the current model.
The procedures for updating Θ i.e., adding, deleting and modifying a spline base and
for updating (β, σ2) are given below.
Adding a spline
The steps to add a basis function to the model is as follows:
1. Draw the interaction level of the spline zj ∼ U(1, . . . , zmax).
2. Draw zj elements {dj1, . . . , djzj} from {1, . . . , p} without replacement.
3. For each of the zj interactions that make up the jth spline: select a data point
at random from the data set, say xi and set the corresponding knot point
θjl = xidjl . Then draw the orientation of the spline from uniform {0, 1}, where
0 corresponds to + (positive orientation) and 1 to − (negative orientation).
4. Update (β, σ2) as given below.
Deleting a spline
Choose one of the k splines at random and remove it from the model and subsequently
update the values of (β, σ2) as shown below
Modifying a spline
The following is the procedure to modify a basis function to the model,
1. Select at random one of the k splines, say the jth, to modify.
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2. Select the lth of the zj interactions at random and reset the knot point θjl by
randomly drawing a data point xi from the data set and fixing the value of
θjl = xidjl .
3. Update (β, σ2) as given below.
Updating the latent variables ω
For the update to ω, we propose to update each ωi in turn conditional on the
rest. That is, we update ωi|ω−i,Y,M (i = 1, . . . , n), where ω−i indicates the ω with
the ith element removed.
The latent variables ωi’s conditional on the current model parameters M and
the data Yi does not have an explicit form. Thus we resort to the Metropolis-Hastings
procedure with a proposal density T (ω∗i |ωi) that generates the moves from the current
state ωi to a new state ω
∗
i . The proposed updates are then accepted with probabilities,
α = min
{
1,
p(yi|ω∗i )p(ω∗i |ω−i,Θ)T (ωi|ω∗i )
p(yi|ωi)p(ωi|ω−i,Θ)T (ω∗i |ωi)
}
,
otherwise the current model is retained.
Finally, the full conditional for ωi is,
p(ωi|ω−i,Y,M) ∝ exp
[
n∑
j=1
Yiωi −
n∑
j=1
log(1 + exp(ωi))− 1
2σ2
(ωi −Θ′iβ)2
]
where Θi is the ith row of MARS basis matrix Θ as given in (3.4).
It is convenient to take the proposal distribution T (ω∗i |ωi) to be a symmetric
distribution (eg. Gaussian) with mean equal to the old value ωi and a pre-specified
standard deviation.
Updating (β, σ2) conditional on changes to the spline base and latent variables ω
Conditional on the latent variables ω and the current MARS model, using Bayesian
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linear model theory we update the spline coefficients and the residual random effects,
given the changes to the spline basis using their posterior distribution, so that
(β, σ2) ∼ Nn+1(β|m, σ2V)IG(σ2|γ˜1, γ˜2),
where m = V (Θ∗)′ω, V = [(Θ∗)′Θ∗ + D]−1, γ˜1 = (γ1 + n/2), and γ˜2 = (γ2 +
(1/2)(ω′ω−m′V m)). Here Θ∗ now is the n× (k+1) matrix of outputs from k splines
with the intercept and D is the prior precision on β.
Updating prior precision λ conditional on the current model
We draw new values of λi using the conditional posterior disribution,
λi ∼ Gamma(τ1 + 1
2
, τ2 +
β′β
2
)
where k is the number of basis functions and β are the regression coefficients.
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